Abstract
Eight volunteers each received lg of probenecid followed immediately by 1.5 g sultamicillin, both given by the oral route. Plasma concentrations of ampicillin and sulbactam were measured using a differential bioassay method. An ampicillin mean peak plasma concentration of 23.1 mg/l was found typically 1.5 h after dosing; the mean peak plasma concentration of sulbactam (10.0 mg/l) occurred at the same time. The mean plasma half-life of ampicillin was 1.45 h and that of sulbactam 1.3 h. The mean urinary recovery of ampicillin was 65 % and that of sulbactam 62 %. Five of the volunteers reported minor changes in bowel habits.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
McCutchan, J. A., Adler, M. W., Berrie, J. R. H.: Penicillinase-producingNeisseria gonorrhoeae in Great Britain, 1977–81; alarming increase in incidence and recent development of endemic transmission. British Medical Journal 1982, 285: 337–340.
Jaffe, H. W., Biddle, J. W., Johnson, S. R., Wiesner, P. J.: Infections due to penicillinase-producingNeisseria gonorrhoeae in the United States: 1976–1980. Journal of Infectious Diseases 1981, 144: 191–197.
van Embden, J. D. A., van Klingeren, B., Dessens-Kroon, M., van Wijngaarden, L. J.: Emergence in the Netherlands of penicillinase-producing gonococci carrying “Africa” plasmid in combination with transfer plasmid. Lancet 1981, i: 938.
De Konig, G. A. J., Tio, D., Coster, J. F., Coutinho, R. A., Ansink-Schipper, M. C.: The combination of clavulanic acid and amoxycillin (Augmentin) in the treatment of patients infected with penicillinase-producing gonococci. Journal of Antimicrobial Chemotherapy 1981, 8: 81–82.
Witkowski, G., Lode, H., Hoffken, G., Koeppe, P.: Pharmacokinetic studies of amoxycillin, potassium clavulanate and their combinations. European Journal of Clinical Microbiology 1982, 1: 233–237.
Hartley, S., Wise, R.: A three-way crossover study to compare the pharmacokinetics and acceptability of sultamicillin at two dose levels with that of ampicillin. Journal of Antimicrobial Chemotherapy 1982, 10: 49–55.
Rogers, H. J., Bradbrook, I. D., Morrison, P. J., Spector, R. G., Cox, D. A., Lees, L. J.: Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography. Journal of Antimicrobial Chemotherapy 1983, 11: 435–445.
Davies, B. I., Maesen, F. P. V., Jevons, S., Brouwers, J.: Combination of sulbactam pivoxyl and bacampicillin in acute exacerbation of chronic bronchitis. Journal of Antimicrobial Chemotherapy 1982, 10: 445–452.
Spengler, P. J., Edwards, L. D.: Comparative study of bacampicillin and ampicillin in the treatment of uncomplicated gonorrhoea. British Journal of Venereal Diseases 1980, 56: 51–55.
Gibaldi, M., Schwartz, M. A.: Apparent effect of probenecid on the distribution of penicillins in man. Clinical Pharmacology and Therapeutics 1968, 9: 345–349.
Roholt, K., Nielsen, B., Kristensen, E.: Clinical pharmacology of pivampicillin. Antimicrobial Agents and Chemotherapy 1974, 6: 563–571.
Atia, W. A., Emmerson, A. M., Holmes, D.: Sultamicillin in the treatment of gonorrhoea caused by penicillin-sensitive and penicillinase-producing strains ofNeisseria gonorrhoeae. British Journal of Venereal Diseases 1983 (in press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Emmerson, A.M., Cox, D.A. & Lees, L.J. Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid. Eur. J, Clin. Microbiol. 2, 340–344 (1983). https://doi.org/10.1007/BF02019464
Issue Date:
DOI: https://doi.org/10.1007/BF02019464